These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22434917)

  • 1. Mood problems increase the risk of mortality in patients with lacunar infarcts: the SMART-MR study.
    Grool AM; van der Graaf Y; Mali WP; Witkamp TD; Vincken KL; Geerlings MI;
    Psychosom Med; 2012 Apr; 74(3):234-40. PubMed ID: 22434917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lacunar infarcts in deep white matter are associated with higher and more fluctuating depressive symptoms during three years follow-up.
    Grool AM; Gerritsen L; Zuithoff NP; Mali WP; van der Graaf Y; Geerlings MI
    Biol Psychiatry; 2013 Jan; 73(2):169-76. PubMed ID: 23079234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral small-vessel disease and progression of brain atrophy: the SMART-MR study.
    Kloppenborg RP; Nederkoorn PJ; Grool AM; Vincken KL; Mali WP; Vermeulen M; van der Graaf Y; Geerlings MI;
    Neurology; 2012 Nov; 79(20):2029-36. PubMed ID: 23115210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral small vessel disease and risk of death, ischemic stroke, and cardiac complications in patients with atherosclerotic disease: the Second Manifestations of ARTerial disease-Magnetic Resonance (SMART-MR) study.
    Conijn MM; Kloppenborg RP; Algra A; Mali WP; Kappelle LJ; Vincken KL; van der Graaf Y; Geerlings MI;
    Stroke; 2011 Nov; 42(11):3105-9. PubMed ID: 21868739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Location and progression of cerebral small-vessel disease and atrophy, and depressive symptom profiles: the Second Manifestations of ARTerial disease (SMART)-Medea study.
    Grool AM; van der Graaf Y; Mali WP; Witkamp TD; Vincken KL; Geerlings MI;
    Psychol Med; 2012 Feb; 42(2):359-70. PubMed ID: 21835088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbleeds, lacunar infarcts, white matter lesions and cerebrovascular reactivity -- a 7 T study.
    Conijn MM; Hoogduin JM; van der Graaf Y; Hendrikse J; Luijten PR; Geerlings MI
    Neuroimage; 2012 Jan; 59(2):950-6. PubMed ID: 21930217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic kidney disease, 24-h blood pressure and small vessel diseases are independently associated with cognitive impairment in lacunar infarct patients.
    Yamamoto Y; Ohara T; Nagakane Y; Tanaka E; Morii F; Koizumi T; Akiguchi I
    Hypertens Res; 2011 Dec; 34(12):1276-82. PubMed ID: 21832998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White matter lesions and lacunar infarcts are independently and differently associated with brain atrophy: the SMART-MR study.
    Appelman AP; Vincken KL; van der Graaf Y; Vlek AL; Witkamp TD; Mali WP; Geerlings MI;
    Cerebrovasc Dis; 2010; 29(1):28-35. PubMed ID: 19893309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of white matter lesions and lacunar infarcts with executive functioning: the SMART-MR study.
    Geerlings MI; Appelman AP; Vincken KL; Mali WP; van der Graaf Y;
    Am J Epidemiol; 2009 Nov; 170(9):1147-55. PubMed ID: 19783584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral Small Vessel Disease Burden and All-Cause Mortality: Mayo Clinic Florida Familial Cerebrovascular Diseases Registry.
    Goldstein ED; Badi MK; Hasan TF; Lesser ER; Hodge DO; Lin MP; Meschia JF
    J Stroke Cerebrovasc Dis; 2019 Dec; 28(12):104285. PubMed ID: 31677962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine and cerebral small vessel disease in patients with symptomatic atherosclerotic disease. The SMART-MR study.
    Kloppenborg RP; Nederkoorn PJ; van der Graaf Y; Geerlings MI
    Atherosclerosis; 2011 Jun; 216(2):461-6. PubMed ID: 21411090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambulatory blood pressure in patients with lacunar stroke: association with total MRI burden of cerebral small vessel disease.
    Klarenbeek P; van Oostenbrugge RJ; Rouhl RP; Knottnerus IL; Staals J
    Stroke; 2013 Nov; 44(11):2995-9. PubMed ID: 23982717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma brain natriuretic peptide is a biomarker for screening ischemic cerebral small vessel disease in patients with hypertension.
    Wei W; Chen Y; Lei D; Zhang Y; Weng X; Zhou Y; Zhang L
    Medicine (Baltimore); 2018 Aug; 97(35):e12088. PubMed ID: 30170428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme and progression of white matter lesions and brain atrophy--the SMART-MR study.
    Jochemsen HM; Geerlings MI; Grool AM; Vincken KL; Mali WP; van der Graaf Y; Muller M
    J Alzheimers Dis; 2012; 29(1):39-49. PubMed ID: 22214784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral white matter lesions and lacunar infarcts contribute to the presence of mild parkinsonian signs.
    de Laat KF; van Norden AG; Gons RA; van Uden IW; Zwiers MP; Bloem BR; van Dijk EJ; de Leeuw FE
    Stroke; 2012 Oct; 43(10):2574-9. PubMed ID: 22858727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total magnetic resonance imaging burden of cerebral small-vessel disease is associated with post-stroke depression in patients with acute lacunar stroke.
    Zhang X; Tang Y; Xie Y; Ding C; Xiao J; Jiang X; Shan H; Lin Y; Li C; Hu D; Li T; Sheng L
    Eur J Neurol; 2017 Feb; 24(2):374-380. PubMed ID: 27933697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline characteristic of patients presenting with lacunar stroke and cerebral small vessel disease may predict future development of depression.
    Pavlovic AM; Pekmezovic T; Zidverc Trajkovic J; Svabic Medjedovic T; Veselinovic N; Radojicic A; Mijajlovic M; Tomic G; Jovanovic Z; Norton M; Sternic N
    Int J Geriatr Psychiatry; 2016 Jan; 31(1):58-65. PubMed ID: 25821003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain volumes and cerebrovascular lesions on MRI in patients with atherosclerotic disease. The SMART-MR study.
    Geerlings MI; Appelman AP; Vincken KL; Algra A; Witkamp TD; Mali WP; van der Graaf Y;
    Atherosclerosis; 2010 May; 210(1):130-6. PubMed ID: 19945704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-rated health status as a risk factor for future vascular events and mortality in patients with symptomatic and asymptomatic atherosclerotic disease: the SMART study.
    Grool AM; van der Graaf Y; Visseren FL; de Borst GJ; Algra A; Geerlings MI;
    J Intern Med; 2012 Sep; 272(3):277-86. PubMed ID: 22257088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular brain lesions, brain atrophy, and cognitive decline. The Second Manifestations of ARTerial disease--Magnetic Resonance (SMART-MR) study.
    Kooistra M; Geerlings MI; van der Graaf Y; Mali WP; Vincken KL; Kappelle LJ; Muller M; Biessels GJ;
    Neurobiol Aging; 2014 Jan; 35(1):35-41. PubMed ID: 23932882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.